Lifevantage Corporation (LFVN) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.142x

Based on the latest financial reports, Lifevantage Corporation (LFVN) has a cash flow conversion efficiency ratio of 0.142x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.77 Million) by net assets ($33.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Lifevantage Corporation (LFVN) market capitalisation for the company's overall valuation and market capitalisation.

Lifevantage Corporation - Cash Flow Conversion Efficiency Trend (1997–2026)

This chart illustrates how Lifevantage Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lifevantage Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lifevantage Corporation ranked by their cash flow conversion efficiency. Explore Lifevantage Corporation earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Daemyung Sonoseason Co.Ltd
KQ:007720
-0.048x
Aerovate Therapeutics Inc
NASDAQ:AVTE
-0.032x
PolyPid
NASDAQ:PYPD
-2.876x
JOONGANG DNM Co.Ltd
KQ:051980
0.004x
Asetek A/S
F:A31
0.018x
MAIA Biotechnology Inc.
NYSE MKT:MAIA
-0.191x
Novonix Ltd
AU:NVX
-0.124x
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
-0.003x

Annual Cash Flow Conversion Efficiency for Lifevantage Corporation (1997–2026)

The table below shows the annual cash flow conversion efficiency of Lifevantage Corporation from 1997 to 2026. View Lifevantage Corporation (LFVN) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-06-30 $33.59 Million $10.24 Million 0.305x -11.08%
2025-06-30 $34.64 Million $11.88 Million 0.343x -26.93%
2024-06-30 $25.99 Million $12.20 Million 0.469x +138.14%
2023-06-30 $34.65 Million $6.83 Million 0.197x -21.97%
2022-06-30 $31.52 Million $7.96 Million 0.253x +16.79%
2021-06-30 $36.81 Million $7.96 Million 0.216x -60.76%
2020-06-30 $33.25 Million $18.33 Million 0.551x -15.74%
2019-06-30 $27.20 Million $17.79 Million 0.654x +8.28%
2018-06-30 $21.95 Million $13.26 Million 0.604x +33.00%
2017-06-30 $14.53 Million $6.60 Million 0.454x -8.73%
2016-06-30 $12.13 Million $6.04 Million 0.498x -87.49%
2015-06-30 $3.33 Million $13.22 Million 3.976x +31.06%
2014-06-30 $3.99 Million $12.11 Million 3.034x +865.89%
2013-06-30 $33.95 Million $10.66 Million 0.314x -54.18%
2012-06-30 $28.28 Million $19.39 Million 0.686x +404.74%
2011-06-30 $-20.81 Million $4.68 Million -0.225x -180.87%
2010-06-30 $-16.17 Million $-4.50 Million 0.278x -63.38%
2009-06-30 $-6.85 Million $-5.21 Million 0.760x +421.97%
2008-06-30 $3.17 Million $-747.78K -0.236x +79.53%
2007-06-30 $2.71 Million $-3.13 Million -1.153x -943.09%
2006-06-30 $8.28 Million $-915.63K -0.111x +58.35%
2005-06-30 $10.98 Million $-2.91 Million -0.265x -105.38%
2004-06-30 $23.49K $-3.04K -0.129x +61.58%
2003-06-30 $29.72K $-9.99K -0.336x +14.57%
2002-06-30 $38.16K $-15.02K -0.394x +96.37%
2000-06-30 $11.74K $-127.38K -10.847x -36121.45%
1999-06-30 $26.95K $-807.00 -0.030x -2950.67%
1998-06-30 $105.66K $111.00 0.001x +109.86%
1997-06-30 $129.70K $-1.38K -0.011x --

About Lifevantage Corporation

NASDAQ:LFVN USA Packaged Foods
Market Cap
$77.67 Million
Market Cap Rank
#20294 Global
#4621 in USA
Share Price
$6.20
Change (1 day)
+0.32%
52-Week Range
$4.02 - $10.70
All Time High
$25.62
About

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Om… Read more